| Bioactivity | RP-182-PEG3-K palmitic acid (Compound 1a) inhibits CD206high M2-like macrophage (IC50 of 3.2 µM) and induces phagocytosis. RP-182-PEG3-K palmitic acid exhibits antitumor efficacy in mouse B16 melanoma allografts[1]. |
| Formula | C99H161N23O16 |
| Molar Mass | 1929.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Singh SS, et al., Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Mol Cancer Ther. 2024 Aug 30. |
RP-182-PEG3-K(palmitic acid)
CAS: F: C99H161N23O16 W: 1929.48
RP-182-PEG3-K palmitic acid (Compound 1a) inhibits CD206high M2-like macrophage (IC50 of 3.2 µM) and induces phagocytos
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.